Illumina is a company that helps doctors find out how well patients are doing after they get treatments for cancer. They have a new tool called MRD technology that can test tiny bits of DNA in the blood to see if there are still any cancer cells left. This is important because it can help doctors know if the treatment is working or not. Illumina is teaming up with Johnson & Johnson, another big company, to make this tool better and more available for everyone who needs it. They want to make a test that is not too expensive, very good at finding cancer cells, and can be done quickly in a lab. This way, doctors can know if their patients are getting better or not much faster. Read from source...

1. The article does not provide any evidence or data to support the claim that current disease-monitoring tools fall short in accurately identifying patients' response to treatment. This is a subjective and vague statement that lacks credibility. A more objective and rigorous analysis would be required to validate this claim, such as comparing the performance of different methods in terms of sensitivity, specificity, precision, and accuracy using real-world data or clinical trials.